Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07063173 · ClinicalTrials.gov registry record · NA
Bioavailability of Ration Items Containing Tart Cherry Extract
A NA study of Bioavailability, sponsored by United States Army Research Institute of Environmental Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07063173: Recruiting NA study of Bioavailability, sponsored by United States Army Research Institute of Environmental Medicine.
NCT07063173 is a NA study of Bioavailability that is actively recruiting participants, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 15 participants, below the 36-participant average among 8 other Bioavailability trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07063173, a NA study of Bioavailability, is actively recruiting participants, sponsored by United States Army Research Institute of Environmental Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.
Primary Outcome
The primary objective of this study is to evaluate the postprandial concentrations of: * nmol/L for anthocyanins \& anthocyanidins (cyanidin-3-glucosylrutinoside, cyanidin-3-rutinoside,cyanidin-3-sophoroside, cyanidin-3-glucoside, cyanidin, peonidin-3-glucoside and pelargonidin); * µmol/L for flavonols (Isorhamnetin-3-rutinoside, kaemperol, and que after consuming a TCP-containing, shelf-stable bar and shelf-stable powdered drink (compared to a non-TCP containing control and a TC-containing com
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo beverage
- DIETARY_SUPPLEMENT Fruit Bar
- DIETARY_SUPPLEMENT Powdered Drink
- DIETARY_SUPPLEMENT Commercially available 100% tart cherry juice
Study Locations (1)
Massachusetts
- USARIEM - Natick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT07063173 shows while recruiting
NCT07063173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 36-participant average among 8 other Bioavailability trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Bioavailability appearing as the primary indexed condition, and to 4 interventions - of which Placebo beverage is the first listed.
NCT07063173 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07063173 about?
NCT07063173 is a clinical study titled "Bioavailability of Ration Items Containing Tart Cherry Extract". To determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.
What is the current status of trial NCT07063173?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-06-14. Estimated completion is 2025-12-31.
What conditions does trial NCT07063173 study?
This clinical trial studies the following conditions: Bioavailability.
What interventions are being tested in trial NCT07063173?
The interventions under investigation include: Placebo beverage (DIETARY_SUPPLEMENT), Fruit Bar (DIETARY_SUPPLEMENT), Powdered Drink (DIETARY_SUPPLEMENT), Commercially available 100% tart cherry juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07063173?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07063173 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bioavailability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07063173's enrollment target sits among peer trials
15 7th of 8 higher than 2 of 8 other Bioavailability trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bioavailability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bioavailability of EPA + DHA in a SMEDS Formulation
COMPLETED · NA
-
Curcumin and Retinal Study
RECRUITING · Phase 1
-
A Study of TEPEZZA Subcutaneous Administration in Healthy Adults
COMPLETED · Phase 1
-
A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects
COMPLETED · Phase 1
-
Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants
COMPLETED · Phase 1
-
Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI